Who can use this medication?

It is suitable for adults and children aged 3 months and older.

What are the available dosage forms?

The product is available as a powder for solution usage.

Where is the factory located?

The factory is located in Jining, Shandong, China.

500mg Meropenem for Injection (GMP medicines manufacture in China)

Name: 500mg Meropenem for Injection (GMP medicines manufacture in China)
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 1981131961

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.0001

100,000 Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

500mg

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

300490

Drug Ad Approval No.

300490

Registration Dossiers

Available

Quality Standard

USP or Bp

Transport Package

Box

Specification

30mg/ml

Trademark

SHENGLU

Origin

China

HS Code

2804290000

Production Capacity

100000000000000/Year

Key features

GMP Certified Manufacturing: Produced in China under strict GMP standards ensuring high quality and safety.

Broad Spectrum Indication: Treats skin, abdominal infections, and meningitis in adults and children 3 months+.

Flexible Customization Options: Offers full, minor, sample-based, and design-based customization services.

USP or BP Quality Standard: Meets international pharmacopoeia standards for drug quality assurance.

Comprehensive OEM/ODM Service: Full OEM and ODM capabilities available for tailored pharmaceutical solutions.

100% Finished Product Inspection: Every unit undergoes visual and functional inspection before shipment.

Established Manufacturer: Operating since 2001 with 153 employees and 7 production lines.

Global Supply Capability: 20 years of export experience serving markets in Africa and domestically.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.